Stockreport

BioTime Announces Issuance of U.S. Patent for Method of Reducing Cavitation in Patients with Acute Spinal Cord Injury

Brooklyn ImmunoTherapeutics, Inc.  (BTX) 
NASDAQ:AMEX Investor Relations: biotimeinc.com/pexservice/investors
PDF ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing cellular therapies f [Read more]